Insider Buy/Sell Details for the Biotechnology Industry — April 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (921)
Vor Biopharma Inc. (VOR)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
458,411
Price
$16.28
Total Value
$7.46M
Shares Held After
2,739,208
% of Holdings
14.3%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
416
Price
$31.33
Total Value
$13.03K
Shares Held After
69,792
% of Holdings
0.6%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
19,060
Price
$14.57
Total Value
$277.70K
Shares Held After
403,822
% of Holdings
4.5%
Nuvation Bio Inc. (NUVB)
Wentworth Kerry — CHIEF REGULATORY OFFICER
Shares
36,750
Price
$5.01
Total Value
$184.28K
Shares Held After
53,000
% of Holdings
40.9%
Nuvation Bio Inc. (NUVB)
Liu Dongfang — CHIEF MEDICAL OFFICER
Shares
50,000
Price
$5.02
Total Value
$251.00K
Shares Held After
18,000
% of Holdings
73.5%
Rapport Therapeutics, Inc. (RAPP)
Yeleswaram Krishnaswamy — Chief Development Officer
Shares
20,225
Price
$39.99
Total Value
$808.84K
Shares Held After
246,426
% of Holdings
7.6%
INCYTE CORP (INCY)
CAGNONI PABLO J — President, Global Head of R&D
Shares
18,667
Price
$96.50
Total Value
$1.80M
Shares Held After
262,692
% of Holdings
6.6%
Dyne Therapeutics, Inc. (DYN)
Kersten Dirk — Director
Shares
211,974
Price
$20.29
Total Value
$4.30M
Shares Held After
4,332,799
% of Holdings
4.7%
Liquidia Corp (LQDA)
JEFFS ROGER — Director
Shares
18,839
Price
$40.60
Total Value
$764.96K
Shares Held After
1,423,095
% of Holdings
1.3%
Onconetix, Inc. (ONCO)
HRT FINANCIAL LP — 10% Owner
Shares
34,636
Price
$0.73
Total Value
$25.28K
Shares Held After
177,821
% of Holdings
19.5%
KalVista Pharmaceuticals, Inc. (KALV)
Palleiko Benjamin L — Director
Shares
9,550
Price
$20.22
Total Value
$193.07K
Shares Held After
462,577
% of Holdings
2.0%
KalVista Pharmaceuticals, Inc. (KALV)
Piekos Brian — Chief Financial Officer
Shares
1,862
Price
$20.22
Total Value
$37.64K
Shares Held After
18,150
% of Holdings
9.3%
KalVista Pharmaceuticals, Inc. (KALV)
Sweeny Nicole — Chief Commercial Officer
Shares
1,862
Price
$20.22
Total Value
$37.64K
Shares Held After
51,391
% of Holdings
3.5%
KalVista Pharmaceuticals, Inc. (KALV)
Audhya Paul K. — CHIEF MEDICAL OFFICER
Shares
2,686
Price
$20.22
Total Value
$54.30K
Shares Held After
142,547
% of Holdings
1.8%
Insight Molecular Diagnostics Inc. (IMDX)
BROADWOOD PARTNERS, L.P. — 10% Owner
Shares
40,114
Price
$3.57
Total Value
$143.25K
Shares Held After
12,074,010
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$592.30
Total Value
$118.46K
Shares Held After
40,513
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
121
Price
$591.10
Total Value
$71.52K
Shares Held After
40,713
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
777
Price
$590.28
Total Value
$458.65K
Shares Held After
40,834
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,088
Price
$589.32
Total Value
$1.23M
Shares Held After
41,611
% of Holdings
4.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,072
Price
$588.44
Total Value
$1.22M
Shares Held After
43,699
% of Holdings
4.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,715
Price
$587.49
Total Value
$1.01M
Shares Held After
45,771
% of Holdings
3.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
888
Price
$586.21
Total Value
$520.56K
Shares Held After
47,486
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
159
Price
$585.33
Total Value
$93.07K
Shares Held After
48,374
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$583.63
Total Value
$23.35K
Shares Held After
48,533
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
20
Price
$579.79
Total Value
$11.60K
Shares Held After
48,573
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
82
Price
$579.05
Total Value
$47.48K
Shares Held After
48,593
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
143
Price
$578.14
Total Value
$82.67K
Shares Held After
48,675
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
307
Price
$577.06
Total Value
$177.16K
Shares Held After
48,818
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
640
Price
$576.14
Total Value
$368.73K
Shares Held After
49,125
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
248
Price
$575.38
Total Value
$142.69K
Shares Held After
49,765
% of Holdings
0.5%
Ginkgo Bioworks Holdings, Inc. (DNA)
Coen Steven P. — Chief Financial Officer
Shares
324
Price
$7.95
Total Value
$2.58K
Shares Held After
50,268
% of Holdings
0.6%
EyePoint, Inc. (EYPT)
Ribeiro Ramiro — Chief Medical Officer
Shares
2,437
Price
$15.00
Total Value
$36.55K
Shares Held After
0
% of Holdings
100.0%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
200
Price
$163.32
Total Value
$32.66K
Shares Held After
13,666
% of Holdings
1.4%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
216
Price
$162.48
Total Value
$35.10K
Shares Held After
13,866
% of Holdings
1.5%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
274
Price
$161.41
Total Value
$44.23K
Shares Held After
14,082
% of Holdings
1.9%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
226
Price
$160.55
Total Value
$36.28K
Shares Held After
14,356
% of Holdings
1.5%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
52
Price
$159.38
Total Value
$8.29K
Shares Held After
14,582
% of Holdings
0.4%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
32
Price
$158.46
Total Value
$5.07K
Shares Held After
14,634
% of Holdings
0.2%
CG Oncology, Inc. (CGON)
Mulay James — Director
Shares
15,600
Price
$73.01
Total Value
$1.14M
Shares Held After
0
% of Holdings
100.0%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
25,040
Price
$6.43
Total Value
$161.01K
Shares Held After
362,729
% of Holdings
6.5%
UNITED THERAPEUTICS Corp (UTHR)
PATUSKY CHRISTOPHER — Director
Shares
1,000
Price
$578.88
Total Value
$578.88K
Shares Held After
1,490
% of Holdings
40.2%
Onconetix, Inc. (ONCO)
HRT FINANCIAL LP — 10% Owner
Shares
53,867
Price
$0.73
Total Value
$39.32K
Shares Held After
143,185
% of Holdings
27.3%
Insight Molecular Diagnostics Inc. (IMDX)
BROADWOOD PARTNERS, L.P. — 10% Owner
Shares
102,057
Price
$3.45
Total Value
$351.66K
Shares Held After
12,033,896
% of Holdings
0.8%
Scholar Rock Holding Corp (SRRK)
Vaishnaw Akshay — Director
Shares
12,246
Price
$49.57
Total Value
$607.09K
Shares Held After
630,542
% of Holdings
1.9%
Scholar Rock Holding Corp (SRRK)
Hallal David — Director
Shares
30,615
Price
$49.57
Total Value
$1.52M
Shares Held After
1,639,034
% of Holdings
1.8%
Scholar Rock Holding Corp (SRRK)
Woods Keith — Chief Operating Officer
Shares
10,220
Price
$49.57
Total Value
$506.65K
Shares Held After
620,055
% of Holdings
1.6%
Scholar Rock Holding Corp (SRRK)
Sinha Vikas — Chief Financial Officer
Shares
10,410
Price
$49.57
Total Value
$516.07K
Shares Held After
619,856
% of Holdings
1.7%
Roivant Sciences Ltd. (ROIV)
Gline Matthew — Director
Shares
289,774
Price
$29.16
Total Value
$8.45M
Shares Held After
16,736,116
% of Holdings
1.7%
COGNITION THERAPEUTICS INC (CGTX)
Ricciardi Lisa — Director
Shares
9,175
Price
$1.10
Total Value
$10.09K
Shares Held After
1,715,851
% of Holdings
0.5%
COGNITION THERAPEUTICS INC (CGTX)
Doyle John Brendan — Chief Financial Officer
Shares
10,000
Price
$1.13
Total Value
$11.30K
Shares Held After
627,509
% of Holdings
1.6%
Showing 101–150 of 921 transactions (page 3 of 19)